QNRX
Price
$4.53
Change
-$0.19 (-4.03%)
Updated
Oct 2, 04:58 PM (EDT)
Capitalization
10.56M
Intraday BUY SELL Signals
TOVX
Price
$0.24
Change
+$0.02 (+9.09%)
Updated
Oct 2, 04:56 PM (EDT)
Capitalization
9.94M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

QNRX vs TOVX

QNRX vs TOVX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
QNRX vs. TOVX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNRX is a Hold and TOVX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
QNRX vs TOVX: Fundamental Ratings
QNRX
TOVX
OUTLOOK RATING
1..100
8777
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8374
P/E GROWTH RATING
1..100
1118
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TOVX's Valuation (19) in the null industry is in the same range as QNRX (26) in the Biotechnology industry. This means that TOVX’s stock grew similarly to QNRX’s over the last 12 months.

TOVX's Profit vs Risk Rating (100) in the null industry is in the same range as QNRX (100) in the Biotechnology industry. This means that TOVX’s stock grew similarly to QNRX’s over the last 12 months.

TOVX's SMR Rating (99) in the null industry is in the same range as QNRX (100) in the Biotechnology industry. This means that TOVX’s stock grew similarly to QNRX’s over the last 12 months.

TOVX's Price Growth Rating (74) in the null industry is in the same range as QNRX (83) in the Biotechnology industry. This means that TOVX’s stock grew similarly to QNRX’s over the last 12 months.

QNRX's P/E Growth Rating (11) in the Biotechnology industry is in the same range as TOVX (18) in the null industry. This means that QNRX’s stock grew similarly to TOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNRXTOVX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (QNRX: $4.72 vs. TOVX: $0.22)
Brand notoriety: QNRX and TOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QNRX: 6% vs. TOVX: 78%
Market capitalization -- QNRX: $10.56M vs. TOVX: $9.94M
QNRX [@Biotechnology] is valued at $10.56M. TOVX’s [@Biotechnology] market capitalization is $9.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNRX’s FA Score shows that 2 FA rating(s) are green while TOVX’s FA Score has 2 green FA rating(s).

  • QNRX’s FA Score: 2 green, 3 red.
  • TOVX’s FA Score: 2 green, 3 red.
According to our system of comparison, both QNRX and TOVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNRX’s TA Score shows that 5 TA indicator(s) are bullish while TOVX’s TA Score has 4 bullish TA indicator(s).

  • QNRX’s TA Score: 5 bullish, 4 bearish.
  • TOVX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, QNRX is a better buy in the short-term than TOVX.

Price Growth

QNRX (@Biotechnology) experienced а -26.02% price change this week, while TOVX (@Biotechnology) price change was -2.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

TOVX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
QNRX
Daily Signal:
Gain/Loss:
TOVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPOF4.660.16
+3.56%
Xponential Fitness
ACHR5.030.06
+1.21%
Archer Aviation
HEI306.393.21
+1.06%
HEICO Corp
DC5.98-0.11
-1.81%
Dakota Gold Corp
AZTR0.13-0.01
-6.61%
Azitra

QNRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with PTGX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
+3.51%
PTGX - QNRX
41%
Loosely correlated
-1.21%
TOVX - QNRX
40%
Loosely correlated
N/A
ATNM - QNRX
35%
Loosely correlated
+2.68%
PRQR - QNRX
32%
Poorly correlated
-1.81%
WVE - QNRX
32%
Poorly correlated
+4.86%
More

TOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOVX has been loosely correlated with GOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TOVX jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOVX
1D Price
Change %
TOVX100%
N/A
GOVX - TOVX
54%
Loosely correlated
-3.56%
GNPX - TOVX
50%
Loosely correlated
-12.33%
VOR - TOVX
42%
Loosely correlated
-5.35%
TVRD - TOVX
41%
Loosely correlated
-0.80%
QNRX - TOVX
40%
Loosely correlated
+3.51%
More